tiprankstipranks
Trending News
More News >
Chembond Chemicals Limited (IN:CHEMBOND)
:CHEMBOND
India Market

Chembond Chemicals Limited (CHEMBOND) AI Stock Analysis

Compare
0 Followers

Top Page

IN:CHEMBOND

Chembond Chemicals Limited

(CHEMBOND)

Select Model
Select Model
Select Model
Neutral 66 (OpenAI - 5.2)
,
Neutral 66 (OpenAI - 5.2)
,
Neutral 66 (OpenAI - 5.2)
Rating:66Neutral
Price Target:
₹151.00
▼(-7.81% Downside)
Action:ReiteratedDate:01/23/26
The score is primarily supported by stable financial positioning (strong equity base, low leverage) and improved cash-flow trends, but is held back by volatile revenue/profitability and a neutral-to-weak technical setup (negative MACD and below longer-term moving averages). Valuation is moderate and modestly supportive.
Positive Factors
Balance Sheet Strength
Chembond's strong equity base and low leverage provide durable financial flexibility. This balance sheet strength supports working capital needs, cushions cyclical downturns in chemicals end markets, and enables strategic spending on R&D or capex without immediate reliance on external financing.
Cash Flow Recovery
Sustained positive operating cash flow and a recent improvement in free cash flow indicate the firm can internally fund operations and some investment. Over the coming months this reduces refinancing risk, supports incremental capex or dividends, and enhances resilience versus peers with weaker cash conversion.
Diverse Industrial End-Markets
Chembond serves multiple industrial and infrastructure segments (water treatment, construction polymers, surface finishing), providing structural diversification. This spread across end-markets helps smooth revenue cyclicality, preserves demand through sector-specific cycles, and leverages technical know-how for repeat business.
Negative Factors
Revenue Volatility & Recent Decline
A sharp recent revenue decline and historically volatile top-line reduce predictability of earnings and cash generation. Over a multi-month horizon this makes budgeting, investment planning, and margin improvement initiatives harder to sustain and increases execution risk for management's growth plans.
Inconsistent Margins
Fluctuating gross and net margins point to inconsistent pricing power or variable input-cost pass-through. Moderate operating margins limit the company's ability to absorb raw material volatility and compressions, threatening sustained profitability and the durability of recent cash-flow improvements.
Limited Scale & Liquidity
Relatively small scale and low trading liquidity constrain economies of scale, bargaining power with large industrial customers, and ability to attract institutional capital. Over the medium term this can limit investment in capacity or R&D and slow market-share gains versus larger specialty-chem peers.

Chembond Chemicals Limited (CHEMBOND) vs. iShares MSCI India ETF (INDA)

Chembond Chemicals Limited Business Overview & Revenue Model

Company DescriptionChembond Material Technologies Ltd. enages in the manufacture and sell of specialty chemicals. Its products include water treatment, polymers, construction chemicals, coatings, animal nutrition's, and industrial biotech products. The company was founded on March 22, 1975 and is headquartered in Mumbai, India.
How the Company Makes Moneynull

Chembond Chemicals Limited Financial Statement Overview

Summary
Financials are mixed: balance sheet strength (low leverage and healthy equity base) supports stability, but revenue and profitability have been volatile. Cash flow remains positive with improved free cash flow, yet inconsistent margins and recent revenue decline limit the score.
Income Statement
68
Positive
Chembond Chemicals has shown a volatile revenue trajectory with a notable decline in the most recent year. The gross profit margin and net profit margin have shown fluctuations, reflecting the company's struggle to maintain consistent profitability. The EBIT and EBITDA margins indicate moderate profitability, suggesting potential for improvement in operational efficiency.
Balance Sheet
75
Positive
The company maintains a strong equity base with a healthy equity ratio, indicating financial stability. The debt-to-equity ratio is low, reflecting prudent leverage management. However, fluctuations in net income have impacted return on equity, suggesting room for improved profitability.
Cash Flow
70
Positive
Despite occasional fluctuations, operating cash flow has remained positive, highlighting potential for stable cash generation. The free cash flow has improved after prior negative figures, indicating better capital expenditure management. The operating cash flow to net income ratio suggests efficient conversion of profits into cash flow.
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue2.94B2.01B1.78B4.40B3.49B2.74B
Gross Profit1.03B517.72M317.75M1.83B612.28M1.14B
EBITDA337.81M227.48M203.90M394.80M194.10M334.04M
Net Income228.91M175.62M111.76M250.96M139.21M203.44M
Balance Sheet
Total Assets2.11B2.02B4.47B4.02B3.61B3.54B
Cash, Cash Equivalents and Short-Term Investments323.26M421.01M258.61M370.15M548.27M473.20M
Total Debt59.90M26.46M68.08M65.25M15.06M18.81M
Total Liabilities496.75M455.74M842.07M785.71M557.71M596.75M
Stockholders Equity1.62B1.56B3.61B3.22B3.04B2.93B
Cash Flow
Free Cash Flow-152.18M153.54M155.21M-124.78M-42.85M206.43M
Operating Cash Flow-39.11M197.25M276.48M21.67M-104.71M250.11M
Investing Cash Flow17.41M-85.75M-217.13M13.56M-18.68M-112.22M
Financing Cash Flow8.19M-87.44M-50.53M-20.57M-40.89M-19.09M

Chembond Chemicals Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price163.80
Price Trends
50DMA
150.39
Negative
100DMA
157.81
Negative
200DMA
179.97
Negative
Market Momentum
MACD
-4.19
Positive
RSI
34.26
Neutral
STOCH
28.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:CHEMBOND, the sentiment is Negative. The current price of 163.8 is above the 20-day moving average (MA) of 144.02, above the 50-day MA of 150.39, and below the 200-day MA of 179.97, indicating a bearish trend. The MACD of -4.19 indicates Positive momentum. The RSI at 34.26 is Neutral, neither overbought nor oversold. The STOCH value of 28.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:CHEMBOND.

Chembond Chemicals Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
₹9.84B17.660.52%28.67%50.12%
66
Neutral
₹1.71B34.221.11%-37.34%-45.55%
62
Neutral
₹6.45B95.100.45%-4.09%-32.35%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
60
Neutral
₹5.49B697.5115.56%2114.71%
59
Neutral
₹10.86B-28.192.59%-10.71%-40.89%
47
Neutral
₹6.47B-2,425.331.07%-22.10%-85.56%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:CHEMBOND
Chembond Chemicals Limited
127.00
-363.48
-74.11%
IN:AGARIND
Agarwal Industrial Corporation Limited
431.35
-548.90
-56.00%
IN:BODALCHEM
Bodal Chemicals Limited
43.60
-16.40
-27.33%
IN:FAIRCHEMOR
Fairchem Organics Ltd
513.80
-436.92
-45.96%
IN:IGPL
IG Petrochemicals Ltd.
352.65
-51.10
-12.66%
IN:SHREEPUSHK
Shree Pushkar Chemicals & Fertilisers Ltd.
304.30
13.99
4.82%

Chembond Chemicals Limited Corporate Events

Chembond Material Technologies Publishes Unaudited Q3 FY26 Results in Newspapers
Jan 18, 2026

Chembond Material Technologies Limited has notified the stock exchanges that it has published the extract of its unaudited financial results for the quarter and nine months ended December 31, 2025 in the English daily Business Standard on January 17, 2026 and the Marathi daily Mumbai Lakshdeep on January 18, 2026. The disclosure, made under SEBI’s listing regulations, underscores the company’s compliance with statutory transparency and reporting requirements for listed entities, ensuring that investors and other stakeholders have public access to its latest financial performance data.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 23, 2026